Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies
description
Transcript of Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies
![Page 1: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/1.jpg)
Institute of MedicineMay 11, 2011
Norman Kahn MDCouncil of Medical Specialty Societies
![Page 2: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/2.jpg)
37 Member Specialty Societies 700,000 physicians in the US Strategic Priorities:
◦ Facilitate a Culture of Performance Improvement in Practice
◦ Model Professionalism Altruism (putting patients’ needs first) Self-regulation Transparency (to peers, patient, the public)
![Page 3: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/3.jpg)
Adopted April 2010, revised March 2011 34 signers to date Independence and transparency CPG’s
◦ Professional responsibility of specialty societies to develop practice guidelines
◦ Evidence-based◦ Independent, transparent development process◦ No company financial support◦ Disclosure, management and resolution of relationships
resulting in perceived conflicts of interest◦ Chair and majority of panel free of relationships◦ Rigorous internal and external review
![Page 4: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/4.jpg)
Conflict of Interest◦ Transparency
Disclosure of relevant relationships Resolution of conflicts of interest
◦ Chair plus majority of writing panel with no relationships (CMSS Code for Interactions with Companies, 2010, revised 2011)
![Page 5: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/5.jpg)
Comprehensive systematic evidence reviews◦ Assessment of the strength of evidence
Recommendations should be actionable ◦ Clear, direct guidance
Recommendations should be practical ◦ Focus on high level evidence
![Page 6: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/6.jpg)
Developer qualifications◦ Methodologist◦ Librarian◦ Multi-disciplinary panel◦ Panel training◦ External review◦ Patient preferences and feedback
![Page 7: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/7.jpg)
Development process◦ Purpose/rationale/clinical question for the
guideline◦ Evidence-grading system disclosed◦ Reconciling low quality evidence◦ Timeline, maintenance and expiration◦ Performance metrics for implementation
![Page 8: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/8.jpg)
Scope◦ Intended audience◦ Patient population◦ Distribution
Web National Guidelines Clearinghouse
![Page 9: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/9.jpg)
Funding◦ No industry support for guideline development
(CMSS Code)◦ Derivative products
![Page 10: Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies](https://reader035.fdocuments.in/reader035/viewer/2022070419/56815c35550346895dca1b18/html5/thumbnails/10.jpg)
Internal CMSS review External review and feedback CMSS Council November 19, 2011